Patient consent is potentially tricky for pharma R&D to navigate as a result of new data protection rules in Europe.
Laura Barrell
Advertisement
Laura Barrell is a specialist Pharmaceuticals and Life Sciences lawyer at VWV, lbarrell@vwv.co.uk.
Articles by Laura Barrell
Advertisement
Latest Updated Articles
- Dual Aspects of Informed vs. Explicit Consent in R&D
Published: July 10th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Standardizing Operations to Meet Global Sustainability and Resilience Goals
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
US and European Pharma Manufacturing Face Diverging Paths to Resilience
5
